Individuals and societal groups are questioning the practice of patenting human genetic material in the context of medical research and health care where diverse ethical, social, and political objections are being raised by critics. A recent case provides a broad legal theory, the common law cause of action, unjust enrichment, and a precedent for challenging the commercialization and patenting of human genetic material.
Greenberg v. Miami Children's Hospital: Unjust Enrichment and the Patenting of Human Genetic Material,
Annals Health L.
Available at: http://lawecommons.luc.edu/annals/vol15/iss2/4